Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience

MeSH terms

• Adult
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antiviral Agents / therapeutic use*
• Drug Administration Schedule
• Drug Therapy, Combination
• Hematopoietic Stem Cell Transplantation*
• Humans
• Immunocompromised Host*
• Male
• Middle Aged
• Palivizumab
• Respiratory Syncytial Virus Infections / drug therapy*
• Ribavirin / therapeutic use*